Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STI-MED-SORB was a medical technology company focused on the development and commercialization of specialized surgical products, particularly in the field of wound management and infection control. The company's primary offering was a line of absorbent surgical materials designed to manage exudate and reduce the risk of surgical site infections. These products were utilized in various clinical settings to improve patient outcomes during and after surgical procedures. While the company was active in the medical device market, it appears to no longer be operating as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STI-MED-SORB.